Impact of Pulmonary Function Measurements on Long-Term Survival After Lobectomy for Stage I Non-Small Cell Lung Cancer Mark F. Berry, MD, Chi-Fu Jeffrey.

Slides:

Advertisements

Similar presentations

Jeffrey M. Griffin, MD, MS, Carolyn E. Reed, MD, Chadrick E

Advertisements

Brandon Stone, MD, Victor S. Mangona, MD, Matthew D

Thoracoscopic lobectomy is associated with lower morbidity than open lobectomy: A propensity-matched analysis from the STS database Subroto Paul, MD,

Elizabeth A. David, MD, David T

Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L

Outcomes of Major Lung Resection After Induction Therapy for Non-Small Cell Lung Cancer in Elderly Patients Chi-Fu Jeffrey Yang, MD, Nicholas R. Mayne,

Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes Meng S. Shao, MD, Andrew T. Wong, MD,

Thomas J. Birdas, MD, Richard P. M

Prediction of Long-Term Survival After Lung Cancer Surgery for Elderly Patients in The Society of Thoracic Surgeons General Thoracic Surgery Database

Comparison of Thoracoscopic Segmentectomy and Thoracoscopic Lobectomy for Small-Sized Stage IA Lung Cancer Chenxi Zhong, MD, Wentao Fang, MD, Teng Mao,

Mark W. Onaitis, MD, Rebecca P. Petersen, MD, John C

A Nomogram to Predict Recurrence and Survival of High-Risk Patients Undergoing Sublobar Resection for Lung Cancer: An Analysis of a Multicenter Prospective.

Usefulness of Lung Perfusion Scintigraphy Before Lung Cancer Resection in Patients with Ventilatory Obstruction Tommaso C. Mineo, MD, Orazio Schillaci,

Brandon Stone, MD, Victor S. Mangona, MD, Matthew D

Chi-Fu Jeffrey Yang, MD, Derek Y. Chan, BSE, Paul J

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD

Impact of Lung Function Changes After Induction Radiochemotherapy on Resected T4 Non-Small Cell Lung Cancer Outcome Jean Perentes, MD, PhD, Sabina Bopp,

Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J

Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases

Glasgow Prognostic Score Class 2 Predicts Prolonged Intensive Care Unit Stay in Patients Undergoing Pneumonectomy Francesco Petrella, MD, Davide Radice,

Lobectomy in Octogenarians With Non-Small Cell Lung Cancer: Ramifications of Increasing Life Expectancy and the Benefits of Minimally Invasive Surgery

Induction Chemotherapy is Not Superior to a Surgery-First Strategy for Clinical N1 Non- Small Cell Lung Cancer Paul J. Speicher, MD, Zachary W. Fitch,

Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer Robert E. Merritt, MD, Chuong D. Hoang, MD,

Jong Ho Cho, MD, Masatsugu Hamaji, MD, Mark S. Allen, MD, Stephen D

How I Teach a Thoracoscopic Lobectomy

A New Method to Predict Postoperative Lung Function: Quantitative Breath Sound Measurements Frank Detterbeck, MD, Merav Gat, MS, Daniel Miller, MD, Seth.

Mark F. Berry, MD, Nestor R. Villamizar-Ortiz, MD, Betty C

Michelle C. Ellis, MD, Brian S. Diggs, PhD, John T. Vetto, MD, Paul H

Surgical Treatment of Metachronous Second Primary Lung Cancer

Minimally Invasive Versus Open Esophagectomy for Esophageal Cancer: A Population- Based Analysis Babatunde A. Yerokun, MD, Zhifei Sun, MD, Chi-Fu Jeffrey.

A Risk Score to Assist Selecting Lobectomy Versus Sublobar Resection for Early Stage Non-Small Cell Lung Cancer Brian C. Gulack, MD, Chi-Fu Jeffrey Yang,

Philip W. Smith, MD, Hongkun Wang, PhD, Leo M. Gazoni, MD, K

Vibration Response Imaging in Prediction of Pulmonary Function After Pulmonary Resection Hyun Koo Kim, MD, PhD, DaeGwang Yoo, MD, Ho Kyung Sung, MD,

Outcome After Lung Volume Reduction Surgery in Patients With Severely Impaired Diffusion Capacity Claudio Caviezel, MD, Nadja Schaffter, Didier Schneiter,

Asad A. Shah, MD, Mathias Worni, MD, MHS, Christopher R

Thomas J. Birdas, MD, Richard P. M

Who Do You Say You Are? The Annals of Thoracic Surgery

Tara R. Semenkovich, MD, MPHS, Christine Frederiksen, MS, Jessica L

Effects of Extended Pleurectomy and Decortication on Quality of Life and Pulmonary Function in Patients With Malignant Pleural Mesothelioma David Burkholder,

Kevin L. Anderson, MHSc, Michael S. Mulvihill, MD, Paul J

Use of Amiodarone After Major Lung Resection

Abel Gómez-Caro, MD, Pedro Arguis, MD The Annals of Thoracic Surgery

Survival After Surgery for Pathologic Stage IA Non-Small Cell Lung Cancer Associated With Idiopathic Pulmonary Fibrosis Yuichi Saito, MD, Yasuyuki Kawai,

Recurrence and Survival After Segmentectomy in Patients With Prior Lung Resection for Early-Stage Non-Small Cell Lung Cancer Lisa M. Brown, MD, Brian.

Risk Factors for Atrial Fibrillation After Lung Cancer Surgery: Analysis of The Society of Thoracic Surgeons General Thoracic Surgery Database Mark Onaitis,

Differences in Patterns of Recurrence in Early-Stage Versus Locally Advanced Non- Small Cell Lung Cancer Feiran Lou, MD, MS, Camelia S. Sima, MD, MS,

Lung Function and ECMO After Lung Transplantation

Patient Preferences in Treatment Choices for Early-Stage Lung Cancer

The Role of Extent of Surgical Resection and Lymph Node Assessment for Clinical Stage I Pulmonary Lepidic Adenocarcinoma: An Analysis of 1991 Patients

Pulmonary Resection for Lung Cancer in Octogenarians

Embolized Methyl Methacrylate to the Right Atrium After Kyphoplasty

High Risk for Thoracotomy but not Thoracoscopic Lobectomy

Douglas E. Paull, MD, Glenda M. Updyke, PA-C, Michael A

Arman Kilic, BS, Matthew J. Schuchert, MD, Brian L

Michael T. Durheim, MD, Sunghee Kim, PhD, Brian C

Specialty Training and Mortality After Esophageal Cancer Resection

Impact of Sublobar Resection on Pulmonary Function: Long-Term Results from American College of Surgeons Oncology Group Z4032 (Alliance) Michael S. Kent,

Predicted Versus Observed FEV1 and Dlco After Major Lung Resection: A Prospective Evaluation at Different Postoperative Periods Alessandro Brunelli,

Pneumonectomy After Chemoradiation Therapy for Non-Small Cell Lung Cancer: Does “Side” Really Matter? Anthony W. Kim, MD, L. Penfield Faber, MD, William.

Effect of Formalin Fixation on Tumor Size Determination in Stage I Non-Small Cell Lung Cancer Po-Kuei Hsu, MD, Hsu-Chih Huang, MD, Chih-Cheng Hsieh,

Large clinical databases for the study of lung cancer: Making up for the failure of randomized trials Chi-Fu Jeffrey Yang, MD, Matthew G. Hartwig, MD,

Clinical Outcome After Pulmonary Resection for Lung Cancer Patients on Hemodialysis Toshiro Obuchi, MD, Wakako Hamanaka, MD, Yasuhiro Yoshida, MD, Jun.

Lobectomy for Lung Cancer at Veterans Administration Medical Center Versus Academic Medical Center Travis Geraci, MD, Vanessa Baratta, MD, John Young,

Survival and Outcomes of Pulmonary Resection for Non-Small Cell Lung Cancer in the Elderly: A Nested Case-Control Study Robert J. Cerfolio, MD, Ayesha.

Mark I. Block, MD The Annals of Thoracic Surgery

The Impact of New Technology on Cardiothoracic Surgical Practice

Domenico Galetta, MD, PhD, Lorenzo Spaggiari, MD, PhD

Early Surgical Results After Pneumonectomy for Non-Small Cell Lung Cancer are not Affected by Preoperative Radiotherapy and Chemotherapy Tomas Gudbjartsson,

Thoracoscopic lobectomy is associated with lower morbidity than open lobectomy: A propensity-matched analysis from the STS database Subroto Paul, MD,

Induction Chemoradiation Is Not Superior to Induction Chemotherapy Alone in Stage IIIA Lung Cancer Asad A. Shah, MD, Mark F. Berry, MD, Ching Tzao, MD,

Presentation transcript:

Impact of Pulmonary Function Measurements on Long-Term Survival After Lobectomy for Stage I Non-Small Cell Lung Cancer Mark F. Berry, MD, Chi-Fu Jeffrey Yang, MD, Matthew G. Hartwig, MD, Betty C. Tong, MD, David H. Harpole, MD, Thomas A. D’Amico, MD, Mark W. Onaitis, MD The Annals of Thoracic Surgery Volume 100, Issue 1, Pages 271-276 (July 2015) DOI: 10.1016/j.athoracsur.2015.02.076 Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Overall survival stratified by percent predicted forced expiratory volume in 1 second (FEV1). (Solid line = FEV1 > 80% predicted; dotted line = FEV1 61% to 80%; dashed line = FEV1 41% to 60% predicted; broken line = FEV1 ≤ 40% predicted.) The Annals of Thoracic Surgery 2015 100, 271-276DOI: (10.1016/j.athoracsur.2015.02.076) Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Overall survival stratified by percent predicted diffusion capacity of lung for carbon monoxide (Dlco). (Solid line = Dlco > 80% predicted; dashed line = Dlco 61% to 80% predicted; dotted line = Dlco 41% to 60% predicted; broken line = Dlco ≤ 40% predicted.) The Annals of Thoracic Surgery 2015 100, 271-276DOI: (10.1016/j.athoracsur.2015.02.076) Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions